Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 18 03:32PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.86 Insider Own- Shs Outstand4.53M Perf Week19.02%
Market Cap21.42M Forward P/E- EPS next Y-0.21 Insider Trans- Shs Float4.08M Perf Month20.87%
Income-7.63M PEG- EPS next Q-0.23 Inst Own8.65% Short Float2.18% Perf Quarter97.95%
Sales0.74M P/S28.94 EPS this Y66.70% Inst Trans- Short Ratio1.21 Perf Half Y93.99%
Book/sh1.38 P/B2.82 EPS next Y78.50% ROA-79.22% Short Interest0.09M Perf Year24.36%
Cash/sh1.62 P/C2.40 EPS next 5Y- ROE-142.49% 52W Range1.81 - 4.48 Perf YTD76.36%
Dividend Est.- P/FCF- EPS past 5Y48.75% ROI-122.03% 52W High-13.40% Beta1.48
Dividend TTM- Quick Ratio4.90 Sales past 5Y-22.15% Gross Margin- 52W Low114.36% ATR (14)0.31
Dividend Ex-Date- Current Ratio4.90 EPS Y/Y TTM50.36% Oper. Margin-1102.96% RSI (14)73.20 Volatility10.33% 9.66%
Employees5 Debt/Eq0.01 Sales Y/Y TTM-8.27% Profit Margin-1027.46% Recom1.00 Target Price14.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q67.30% Payout- Rel Volume2.65 Prev Close3.64
Sales Surprise0.00% EPS Surprise6.17% Sales Q/Q-21.32% EarningsMay 30 Avg Volume73.34K Price3.88
SMA2034.68% SMA5047.05% SMA20072.31% Trades Volume181,062 Change6.59%
Date Action Analyst Rating Change Price Target Change
Aug-11-17Initiated Maxim Group Buy $7
Oct-19-16Resumed ROTH Capital Buy
Aug-29-16Resumed Rodman & Renshaw Buy $6
Nov-30-15Reiterated H.C. Wainwright Buy $4 → $6
Mar-31-15Reiterated H.C. Wainwright Buy $7 → $3
Mar-30-15Downgrade ROTH Capital Buy → Neutral $20 → $2.40
Dec-29-14Reiterated ROTH Capital Buy $28 → $20
Nov-18-14Initiated H.C. Wainwright Buy $7
Jul-17-24 07:00AM
Jul-11-24 07:00AM
Jul-01-24 07:00AM
Jun-28-24 07:00AM
Jun-24-24 07:00AM
07:00AM Loading…
Jun-10-24 07:00AM
Jun-05-24 07:00AM
May-29-24 07:00AM
May-27-24 07:00AM
May-23-24 07:00AM
May-13-24 07:00AM
May-10-24 09:00AM
May-09-24 07:00AM
May-06-24 07:00AM
09:00AM Loading…
Apr-29-24 09:00AM
Apr-25-24 07:00AM
Apr-15-24 07:00AM
Apr-03-24 07:00AM
Apr-01-24 07:00AM
Mar-28-24 07:00AM
Mar-11-24 07:00AM
Feb-28-24 07:00AM
Jan-30-24 07:00AM
Jan-29-24 07:00AM
Dec-20-23 07:00AM
Dec-18-23 07:00AM
Dec-04-23 07:00AM
Nov-30-23 07:00AM
Nov-22-23 07:23AM
01:53PM Loading…
Nov-21-23 01:53PM
Nov-01-23 07:00AM
Oct-30-23 09:55AM
Oct-27-23 10:00AM
Oct-26-23 07:00AM
Oct-09-23 07:00AM
Sep-27-23 07:00AM
Sep-07-23 07:00AM
Aug-31-23 07:00AM
Aug-24-23 07:10AM
Aug-18-23 07:00AM
Aug-08-23 07:00AM
Jul-17-23 07:00AM
Jul-11-23 07:00AM
Jul-07-23 07:00AM
Jun-29-23 07:00AM
Jun-14-23 12:17PM
Jun-13-23 07:00AM
Jun-02-23 07:00AM
Jun-01-23 07:00AM
May-30-23 07:00AM
May-15-23 07:00AM
May-10-23 12:00PM
May-09-23 07:00AM
May-02-23 07:00AM
Apr-24-23 07:00AM
Apr-10-23 07:00AM
Mar-30-23 07:15AM
Mar-16-23 07:00AM
Mar-13-23 07:00AM
Feb-14-23 07:00AM
Jan-24-23 07:00AM
Jan-11-23 09:04AM
Jan-10-23 07:00AM
Dec-30-22 04:30PM
Dec-29-22 10:18AM
Dec-28-22 10:21AM
Dec-27-22 08:00AM
Dec-08-22 07:00AM
Nov-25-22 07:00AM
Nov-10-22 02:13PM
Nov-04-22 10:54AM
Nov-02-22 07:15AM
Oct-31-22 09:15AM
Oct-25-22 07:00AM
Oct-13-22 07:00AM
Sep-23-22 08:00AM
Sep-12-22 07:00AM
Aug-25-22 07:00AM
Aug-23-22 07:00AM
Aug-22-22 07:00AM
Aug-17-22 07:25AM
Jul-11-22 07:00AM
Jun-29-22 07:46AM
Jun-24-22 07:00AM
Jun-09-22 07:00AM
May-26-22 07:00AM
May-16-22 07:00AM
May-02-22 07:00AM
Apr-05-22 07:00AM
Mar-28-22 07:00AM
Mar-24-22 08:30AM
Mar-14-22 07:00AM
Mar-11-22 07:00AM
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.